- Home
- Labeler Index
- Takeda Pharmaceuticals America, Inc.
- 63020-535
- NDC Crossover: 63020-535 Iclusig
NDC Crossover 63020-535 Iclusig
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Ponatinib Hydrochloride
The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.
Explore similar products to 63020-535 – Iclusig, a human prescription drug. This list includes other cross-matching products that share:
- The same product name: Iclusig
- OR Generic name: Ponatinib Hydrochloride
- AND the same Administration Route: oral
- OR Dosage Form: tablet, film coated
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
|---|---|---|---|---|---|---|
| 63020-533 | Iclusig | Ponatinib Hydrochloride | Tablet, Film Coated | Oral | Takeda Pharmaceuticals America, Inc. | Human Prescription Drug |
| 63020-534 | Iclusig | Ponatinib Hydrochloride | Tablet, Film Coated | Oral | Takeda Pharmaceuticals America, Inc. | Human Prescription Drug |
| 63020-536 | Iclusig | Ponatinib Hydrochloride | Tablet, Film Coated | Oral | Takeda Pharmaceuticals America, Inc. | Human Prescription Drug |
